Agenus Inc. (AGEN) Fundamentals

Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
SHARE INFORMATION
Market CapUS$ 807.750.965
Shares Outstanding304.811.685
Float289.438.631
Percent Float94,96%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 295.664.000
Latest Fiscal EPSUS$ -0,21
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions320
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months33.126.725
Institutional Holdings Percent88,6%
Institutional Sold Previous 3 Months14.614.423
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months34.397
Insider Holdings Percent2,6
Insider Sold Previous 3 Months-
Insider Shares Owned7.975.641
TRADING INFO
52 Week HighUS$ 3,37
52 Week LowUS$ 1,25
52 Week High ChangeUS$ 5,58
21 Day Moving AverageUS$ 2,6129
21 Day Extended Moving AverageUS$ 2,5926
50 Day Moving AverageUS$ 2,5976
50 Day Extended Moving AverageUS$ 2,5837
200 Day Moving AverageUS$ 2,3723
200 Day Extended Moving AverageUS$ 2,6303
10 Day Average Volume4.860.965
20 Day Average Volume4.328.967
30 Day Average Volume4.085.881
50 Day Average Volume3.971.909
Alpha0.007894
Beta1.3089
Standard Deviation0.225645
R20.098165
7 Day Price ChangeUS$ 0,21
7 Day Percent Change8,61%
21 Day Price ChangeUS$ -0,22
21 Day Percent Change-7,67%
30 Day Price ChangeUS$ 0,25
30 Day Percent Change10,42%
Month to Date Price ChangeUS$ 0,04
Month to Date Percent Change1,53%
Quarter to Date Price ChangeUS$ 0,25
Quarter to Date Percent Change10,42%
180 Day Price ChangeUS$ 0,08
180 Day Percent Change3,11%
200 Day Price ChangeUS$ -0,23
200 Day Percent Change-7,99%
Year to Date Price ChangeUS$ 0,25
Year to Date Percent Change10,42%

Agenus Inc. (AGEN) Key Ratios

PROFITABILITY
EBIT Margin-181,4%
EBITDA Margin-173,9%
Pre-Tax Profit Margin-277,9%
Profit Margin Count0,57%
Gross Margin-303,1%
Profit Margin TOT0,57%
INCOME STATEMENTS
RevenueUS$ 69.638.000
Revenue Per ShareUS$ 0,2285
Revenue (3 Years)US$ -6,16
Revenue (5 Years)US$ 29,39
FINANCIAL STRENGTH
Price to Tangible Book-15,40
Total Debt To Equity23,50
Int Coverage-2,70
Current Ratio1,50
Leverage Ratio-1.060,40
Quick Ratio1,30
Long Term Debt To Capital0,95
VALUATION MEASURES
PE Ratio-3,10
Enterprise ValueUS$ 650.405.264
Price to Sales11,5993
Price to Free Cash-4,60
PE High Last 5 Years-3,10
Price To Book218,60
Price To Cash Flow50,00
PE Low Last 5 Years-2,40
Price to Tangible Book-15,40
MANAGEMENT EFFECTIVENESS
Receivables Turnover3,90
Invoice Turnover0,00
Assets Turnover0,10
Return Assets-51,80
Return on Equity-2.090,88
Return on Capital-210,43

Agenus Inc. (AGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOGaro H. Armen
Emplyoees441
Last AuditUQ
CIK0001098972
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address3 Forbes Road
Lexington, MA 02421-7305
Websitehttps://www.agenusbio.com
Facsimile+1 781 674-4200
Telephone+1 781 674-4400
Emailinvestor@agenusbio.com
Kürzlich von Ihnen besucht
NASDAQ
AGEN
Agenus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Melden Sie sich bei ADVFN an
Jetzt registrieren
Der Markt LS (Lang&Schwarz) wird als Realtime Indikation kostenlos angezeigt und bietet Ihnen außerbörsliche Realtime Aktienkurse in der Zeit von Mo-Fr 08:00 bis 23:00, Samstags 10:00 bis 13:00 und Sonntags an.
NYSE und AMEX Kurse sind um mindestens 20 Minuten zeitverzögert.
Alle weiteren Kurse sind um mindestens 15 Minuten zeitverzögert, sofern nicht anders angegeben.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V:de D:20230204 13:23:58